These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37442065)

  • 1. The immune activity of selective estrogen receptor modulators is gene and macrophage subtype-specific yet converges on Il1b downregulation.
    Sfogliarini C; Pepe G; Cesta CM; Allegretti M; Locati M; Vegeto E
    Biomed Pharmacother; 2023 Sep; 165():115008. PubMed ID: 37442065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen.
    Pepe G; Sfogliarini C; Rizzello L; Battaglia G; Pinna C; Rovati G; Ciana P; Brunialti E; Mornata F; Maggi A; Locati M; Vegeto E
    Biomed Pharmacother; 2021 Dec; 144():112274. PubMed ID: 34653752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.
    Fernández-Suárez ME; Escolà-Gil JC; Pastor O; Dávalos A; Blanco-Vaca F; Lasunción MA; Martínez-Botas J; Gómez-Coronado D
    Sci Rep; 2016 Sep; 6():32105. PubMed ID: 27601313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.
    Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M
    J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
    Suuronen T; Nuutinen T; Huuskonen J; Ojala J; Thornell A; Salminen A
    Inflamm Res; 2005 May; 54(5):194-203. PubMed ID: 15953991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
    Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
    PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for an ideal SERM: Mining tamoxifen structure-activity relationships.
    Price S; Bender SG; Yahn R; Till NA; Varady S; LaLonde RL
    Bioorg Med Chem Lett; 2021 Nov; 52():128383. PubMed ID: 34592434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations.
    Fan P; Craig Jordan V
    Steroids; 2014 Nov; 90():44-52. PubMed ID: 24930824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
    Lamas AZ; Nascimento AM; Medeiros ARS; Caliman IF; Dalpiaz PLM; Firmes LB; Sousa GJ; Oliveira PWC; Andrade TU; Reis AM; Gouvea SA; Bissoli NS
    Pharmacol Rep; 2017 Aug; 69(4):798-805. PubMed ID: 28591668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene.
    Miki Y; Suzuki T; Nagasaki S; Hata S; Akahira J; Sasano H
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):281-9. PubMed ID: 19429434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.
    Levy N; Tatomer D; Herber CB; Zhao X; Tang H; Sargeant T; Ball LJ; Summers J; Speed TP; Leitman DC
    Mol Endocrinol; 2008 Feb; 22(2):287-303. PubMed ID: 17962382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms involved in the protective actions of Selective Estrogen Receptor Modulators in brain cells.
    Baez-Jurado E; Rincón-Benavides MA; Hidalgo-Lanussa O; Guio-Vega G; Ashraf GM; Sahebkar A; Echeverria V; Garcia-Segura LM; Barreto GE
    Front Neuroendocrinol; 2019 Jan; 52():44-64. PubMed ID: 30223003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation.
    Nalbandian G; Paharkova-Vatchkova V; Mao A; Nale S; Kovats S
    J Immunol; 2005 Aug; 175(4):2666-75. PubMed ID: 16081843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulators, acting as agonists of estrogen receptor α in osteoblasts, reduce the TGF-β-induced synthesis of macrophage colony-stimulating factor via inhibition of JNK signaling pathway.
    Hioki T; Matsushima-Nishiwaki R; Tokuda H; Kozawa O
    Biomed Res; 2022; 43(6):211-221. PubMed ID: 36517023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential SERM effects on corepressor binding dictate ERalpha activity in vivo.
    Webb P; Nguyen P; Kushner PJ
    J Biol Chem; 2003 Feb; 278(9):6912-20. PubMed ID: 12482846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
    Thiebaud D; Secrest RJ
    Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SERMs Promote Anti-Inflammatory Signaling and Phenotype of CD14+ Cells.
    Polari L; Wiklund A; Sousa S; Kangas L; Linnanen T; Härkönen P; Määttä J
    Inflammation; 2018 Aug; 41(4):1157-1171. PubMed ID: 29574654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.